Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis

Journal of Receptors and Signal Transduction

Volumn 35, Issue 6, 2015, Pages 600-604

  Sun, Yu ^a   Liu, Wen Zhou ^a   Liu, Tao ^a   Feng, Xu ^a   Yang, Nuo ^a   Zhou, Hua Fu ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Extracellular signal regulated kinase; mitogen activated protein kinases; signaling pathway

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CALCITONIN GENE RELATED PEPTIDE; CASPASE 3; CELECOXIB; CHLORIDE; ENZASTAURIN; ERYTHROPOIETIN; FLAVONOID; LENALIDOMIDE; LEUCINE RICH REPEAT KINASE 2; LOCAL ANESTHETIC AGENT; MESOTHELIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 12; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; OCHRATOXIN; OSTEOPONTIN; QUERCETIN; STRESS ACTIVATED PROTEIN KINASE 1; TRICHOSTATIN A; VASOPRESSIN;

APOPTOSIS; AUTOPHAGY; CARDIOVASCULAR SYSTEM; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DIGESTIVE SYSTEM; DNA DAMAGE; ENZYME INHIBITION; HEART MUSCLE CELL; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOLOGY; NECROTIZING ENTEROCOLITIS; NEOPLASM; NERVOUS SYSTEM; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSONISM; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRAUMATIC BRAIN INJURY; UROGENITAL SYSTEM; CELL AGING; CELL MOTION; METABOLISM; PHYSIOLOGY;

APOPTOSIS; CELL AGING; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 84945310626     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2015.1030412     Document Type: Review

References (77)

1. Pan HC, Jiang Q, Yu Y, et al. Quercetin promotes cell apoptosis and inhibits the expression of MMP-9 and fibronectin via the AKT and ERK signalling pathways in human glioma cells. Neurochem Int 2015;80:60-71.
2. Guo G, Yao W, Zhang Q, Bo Y. Oleanolic acid suppresses migration and invasion of malignant glioma cells by inactivating MAPK/ERK signaling pathway. PLoS One 2013;8:e72079.
3. Cha JH, Choi YJ, Cha SH, et al. Allicin inhibits cell growth and induces apoptosis in U87MG human glioblastoma cells through an ERK-dependent pathway. Oncol Rep 2012;28:41-8.
4. Tian Y, Guan Y, Jia Y, et al. Chloride intracellular channel 1 regulates prostate cancer cell proliferation and migration through the MAPK/ERK pathway. Cancer Biother Radiopharm 2014;29: 339-44.
5. Nikhil K, Sharan S, Chakraborty A, Roy P. Pterostilbene-isothiocyanate conjugate suppresses growth of prostate cancer cells irrespective of androgen receptor status. PLoS One 2014;9:e93335.
6. Zhan YH, Liu J, Qu XJ, et al. Beta-elemene induces apoptosis in human renal-cell carcinoma 786-0 cells through inhibition of MAPK/ERK and PI3K/Akt/mTOR signalling pathways. Asian Pac J Cancer Prev 2012;13:2739-44.
7. Zheng Y, Wang X, Wang H, et al. Expression of the lysyl oxidase propeptide in hepatocellular carcinoma and its clinical relevance. Oncol Rep 2014;31:1669-76.
8. Zhang R, Wang J, Ma S, et al. Requirement of osteopontin in the migration and protection against taxol-induced apoptosis via the ATX-LPA axis in SGC7901 cells. BMC Cell Biol 2011;12:11.
9. Xavier CP, Lima CF, Fernandes-Ferreira M, Pereira-Wilson C. Salvia fruticosa, Salvia officinalis, and rosmarinic acid induce apoptosis and inhibit proliferation of human colorectal cell lines: the role in MAPK/ERK pathway. Nutr Cancer 2009;61:564-71.
10. Park HK, Kim IH, Kim J, Nam TJ. Induction of apoptosis by laminarin, regulating the insulin-like growth factor-IR signaling pathways in HT-29 human colon cells. Int J Mol Med 2012;30: 734-8.
11. Qu J, Zhao M, Teng Y, et al. Interferon-alpha sensitizes human gastric cancer cells to TRAIL-induced apoptosis via activation of the c-CBL-dependent MAPK/ERK pathway. Cancer Biol Ther 2011;12:494-502.
12. Kim TI, Jin SH, Kim WH, et al. Prolonged activation of mitogenactivated protein kinases during NSAID-induced apoptosis in HT-29 colon cancer cells. Int J Colorectal Dis 2001;16:167-73.
13. Sutter AP, Maaser K, Gerst B, et al. Enhancement of peripheral benzodiazepine receptor ligand-induced apoptosis and cell cycle arrest of esophageal cancer cells by simultaneous inhibition of MAPK/ERK kinase. Biochem Pharmacol 2004;67:1701-10.
14. Chang YC, Hsu YC, Liu CL, et al. Local anesthetics induce apoptosis in human thyroid cancer cells through the mitogenactivated protein kinase pathway. PLoS One 2014;9:e89563.
15. Roy SK, Srivastava RK, Shankar S. Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J Mol Signal 2010;5:10.
16. Das S, Dey KK, Bharti R, et al. PKI 166 induced redox signalling and apoptosis through activation of p53, MAP kinase and caspase pathway in epidermoid carcinoma. J Exp Ther Oncol 2012;10: 139-53.
17. Carlo-Stella C, Locatelli SL, Giacomini A, et al. Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells. PLoS One 2013;8:e61603.
18. Lee SY, Shin SJ, Kim HS. ERK1/2 activation mediated by the nutlin3induced mitochondrial translocation of p53. Int J Oncol 2013;42:1027-35.
19. Gao J, Zhao Y, Lv Y, et al. Mirk/Dyrk1B mediates G0/G1 to S phase cell cycle progression and cell survival involving MAPK/ERK signaling in human cancer cells. Cancer Cell Int 2013;13:2.
20. Zhang Y, Song M, Cui ZS, et al. Down-regulation of TSG101 by small interfering RNA inhibits the proliferation of breast cancer cells through the MAPK/ERK signal pathway. Histol Histopathol 2011;26:87-94.
21. Watanabe M, Naraba H, Sakyo T, Kitagawa T. DNA damageinduced modulation of GLUT3 expression is mediated through p53-independent extracellular signal-regulated kinase signaling in HeLa cells. Mol Cancer Res 2010;8:1547-57.
22. Sarkar S, Mazumdar A, Dash R, et al. ZD6474, a dual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERK and AKT/PI3-K and induces apoptosis in breast cancer cells. Cancer Biol Ther 2010;9:592-603.
23. Miao JH, Wang SQ, Zhang MH, et al. Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway. Oncol Rep 2014;32: 1497-504.
24. Choi CH, Lee BH, Ahn SG, Oh SH. Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3beta. Biochem Biophys Res Commun 2012;418:759-64.
25. Chang MC, Chen CA, Chen PJ, et al. Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways. Biochem J 2012;442:293-302.
26. Noh K, Kim KO, Patel NR, et al. Targeting inflammatory kinase as an adjuvant treatment for osteosarcomas. J Bone Joint Surg Am 2011;93:723-32.
27. Wang Z, Luo F, Li L, et al. STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling. Eur J Cancer 2010;46:2996-3006.
28. Aoudjit F, Guo W, Gagnon-Houde JV, et al. HLA-DR signaling inhibits Fas-mediated apoptosis in A375 melanoma cells. Exp Cell Res 2004;299:79-90.
29. Umoh NA, Walker RK, Millis RM, et al. Calcitonin gene-related peptide regulates cardiomyocyte survival through regulation of oxidative stress by PI3K/Akt and MAPK signaling pathways. Ann Clin Exp Hypertens 2014;2:1007.
30. Liu Q, Hofmann PA. Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes. Am J Physiol Heart Circ Physiol 2004;286:H2204-12.
31. Wang L, Li X, Zhou Y, et al. Downregulation of miR-133 via MAPK/ERK signaling pathway involved in nicotine-induced cardiomyocyte apoptosis. Naunyn Schmiedebergs Arch Pharmacol 2014;387:197-206.
32. Li MQ, Shao J, Meng YH, et al. NME1 suppression promotes growth, adhesion and implantation of endometrial stromal cells via Akt and MAPK/Erk1/2 signal pathways in the endometriotic milieu. Hum Reprod 2013;28:2822-31.
33. Sheikh AQ, Taghian T, Hemingway B, et al. Regulation of endothelial MAPK/ERK signalling and capillary morphogenesis by low-amplitude electric field. J R Soc Interface 2013;10:20120548.
34. Gupta K, Kshirsagar S, Li W, et al. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp Cell Res 1999;247: 495-504.
35. Chen J, Aguilera G. Vasopressin protects hippocampal neurones in culture against nutrient deprivation or glutamate-induced apoptosis. J Neuroendocrinol 2010;22:1072-81.
36. Zou X, Gao J, Zheng Y, et al. Zeaxanthin induces Nrf2-mediated phase II enzymes in protection of cell death. Cell Death Dis 2014;5: e1218.
37. Hossain MS, Ifuku M, Take S, et al. Plasmalogens rescue neuronal cell death through an activation of AKT and ERK survival signaling. PLoS One 2013;8:e83508.
38. Hu S, Cui W, Mak S, et al. Bis(propyl)-cognitin protects against glutamate-induced neuro-excitotoxicity via concurrent regulation of NO, MAPK/ERK and PI3-K/Akt/GSK3beta pathways. Neurochem Int 2013;62:468-77.
39. Kim SW, Lim CM, Kim JB, et al. Extracellular HMGB1 released by NMDA treatment confers neuronal apoptosis via RAGE-p38 MAPK/ERK signaling pathway. Neurotox Res 2011;20:159-69.
40. Lim JY, Park SI, Oh JH, et al. Brain-derived neurotrophic factor stimulates the neural differentiation of human umbilical cord bloodderived mesenchymal stem cells and survival of differentiated cells through MAPK/ERK and PI3K/Akt-dependent signaling pathways. J Neurosci Res 2008;86:2168-78.
41. Lallemend F, Lefebvre PP, Hans G, et al. Substance P protects spiral ganglion neurons from apoptosis via PKC-Ca2+-MAPK/ERK pathways. J Neurochem 2003;87:508-21.
42. Anderson CN, Tolkovsky AM. A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JNKindependent induction of apoptosis by cytosine arabinoside. J Neurosci 1999;19:664-73.
43. Marques-Fernandez F, Planells-Ferrer L, Gozzelino R, et al. TNFalpha induces survival through the FLIP-L-dependent activation of the MAPK/ERK pathway. Cell Death Dis 2013;4:e493.
44. Fang XX, Jiang XL, Han XH, et al. Neuroprotection of interleukin- 6 against NMDA-induced neurotoxicity is mediated by JAK/STAT3, MAPK/ERK, and PI3K/AKT signaling pathways. Cell Mol Neurobiol 2013;33:241-51.
45. Gupta VK, You Y, Li JC, et al. Protective effects of 7,8-dihydroxyflavone on retinal ganglion and RGC-5 cells against excitotoxic and oxidative stress. J Mol Neurosci 2013;49:96-104.
46. Zhao Y, Luo P, Guo Q, et al. Interactions between SIRT1 and MAPK/ERK regulate neuronal apoptosis induced by traumatic brain injury in vitro and in vivo. Exp Neurol 2012;237:489-98.
47. Bravo-San Pedro JM, Niso-Santano M, Gomez-Sanchez R, et al. The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway. Cell Mol Life Sci 2013;70: 121-36.
48. Ozcan Z, Gul G, Yaman I. Ochratoxin A activates opposing c-MET/PI3K/Akt and MAPK/ERK 1-2 pathways in human proximal tubule HK-2 cells. Arch Toxicol DOI: 10.1007/s00204-014-1311-x.
49. Zhang X, Liang D, Guo B, et al. Zinc inhibits high glucose-induced apoptosis in peritoneal mesothelial cells. Biol Trace Elem Res 2012;150:424-32.
50. Xu T, Wang NS, Fu LL, et al. Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway. Mol Biol Rep 2012;39:7743-53.
51. Yoshikawa M, Hishikawa K, Idei M, Fujita T. Trichostatin a prevents TGF-beta1-induced apoptosis by inhibiting ERK activation in human renal tubular epithelial cells. Eur J Pharmacol 2010; 642:28-36.
52. Wan-Xin T, Tian-Lei C, Ben W, et al. Effect of mitofusin 2 overexpression on the proliferation and apoptosis of high-glucoseinduced rat glomerular mesangial cells. J Nephrol 2012;25: 1023-30.
53. Jo SK, Cho WY, Sung SA, et al. MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. Kidney Int 2005;67:458-66.
54. Romero-Ramirez H, Morales-Guadarrama MT, Pelayo R, et al. CD38 expression in early B cell precursors contributes to ERKmediated apoptosis. Immunology 2014.
55. Soderstrom TS, Poukkula M, Holmstrom TH, et al. Mitogenactivated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8. J Immunol 2002;169:2851-60.
56. Holmstrom TH, Schmitz I, Soderstrom TS, et al. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. EMBO J 2000;19:5418-28.
57. Yu Y, Shiou SR, Guo Y, et al. Erythropoietin protects epithelial cells from excessive autophagy and apoptosis in experimental neonatal necrotizing enterocolitis. PLoS One 2013;8:e69620.
58. Tseng HL, Li CJ, Huang LH, et al. Quercetin 3-O-methyl ether protects FL83B cells from copper induced oxidative stress through the PI3K/Akt and MAPK/Erk pathway. Toxicol Appl Pharmacol 2012;264:104-13.
59. Li Q, Huai L, Zhang C, et al. Icaritin induces AML cell apoptosis via the MAPK/ERK and PI3K/AKT signal pathways. Int J Hematol 2013;97:617-23.
60. Cosenza M, Civallero M, Grisendi G, et al. Combination of low doses of enzastaurin and lenalidomide has synergistic activity in Bnon-Hodgkin lymphoma cell lines. Ann Hematol 2012;91:1613-22.
61. Naci D, El Azreq MA, Chetoui N, et al. alpha2beta1 integrin promotes chemoresistance against doxorubicin in cancer cells through extracellular signal-regulated kinase (ERK). J Biol Chem 2012;287:17065-76.
62. Herishanu Y, Gibellini F, Njuguna N, et al. Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1. Leuk Lymphoma 2011;52:1758-69.
63. Smal C, Lisart S, Ferrant A, et al. Inhibition of the ERK pathway promotes apoptosis induced by 2-chloro-2′-deoxyadenosine in the B-cell leukemia cell line EHEB. Nucleosides Nucleotides Nucleic Acids 2006;25:1009-12.
64. Kandilci A, Grosveld GC. SET-induced calcium signaling and MAPK/ERK pathway activation mediate dendritic cell-like differentiation of U937 cells. Leukemia 2005;19:1439-45.
65. Gendron S, Couture J, Aoudjit F. Integrin alpha2beta1 inhibits Fasmediated apoptosis in T lymphocytes by protein phosphatase 2Adependent activation of the MAPK/ERK pathway. J Biol Chem 2003;278:48633-43.
66. Xu S, Yang Y, Han S, Wu Z. ZIP1 and zinc inhibits fluorideinduced apoptosis in MC3T3-E1 cells. Biol Trace Elem Res 2014; 159:399-409.
67. Scuderi S, D'Amico AG, Castorina A, et al. Davunetide (NAP) protects the retina against early diabetic injury by reducing apoptotic death. J Mol Neurosci 2014;54:395-404.
68. Kun D, Xiang-Lin C, Ming Z, Qi L. Chlamydia inhibit host cell apoptosis by inducing Bag-1 via the MAPK/ERK survival pathway. Apoptosis 2013;18:1083-92.
69. Liang D, Xiang L, Yang M, et al. ZnT7 can protect MC3T3-E1 cells from oxidative stress-induced apoptosis via PI3K/Akt and MAPK/ERK signaling pathways. Cell Signal 2013;25:1126-35.
70. Zhu X, Jiang Y, Shan PF, et al. Vaspin attenuates the apoptosis of human osteoblasts through ERK signaling pathway. Amino Acids 2013;44:961-8.
71. Li J, Liu S, Li W, et al. Vascular smooth muscle cell apoptosis promotes transplant arteriosclerosis through inducing the production of SDF-1alpha. Am J Transplant 2012;12:2029-43.
72. Chera S, Ghila L, Wenger Y, Galliot B. Injury-induced activation of the MAPK/CREB pathway triggers apoptosis-induced compensatory proliferation in hydra head regeneration. Dev Growth Differ 2011;53:186-201.
73. Karube H, Nishitai G, Inageda K, et al. NaF activates MAPKs and induces apoptosis in odontoblast-like cells. J Dent Res 2009;88: 461-5.
74. Kornasio R, Riederer I, Butler-Browne G, et al. Beta-hydroxy-betamethylbutyrate (HMB) stimulates myogenic cell proliferation, differentiation and survival via the MAPK/ERK and PI3K/Akt pathways. Biochim Biophys Acta 2009;1793:755-63.
75. Du MR, Zhou WH, Yan FT, et al. Cyclosporine A induces titin expression via MAPK/ERK signalling and improves proliferative and invasive potential of human trophoblast cells. Hum Reprod 2007;22:2528-37.
76. Sanna B, Debidda M, Pintus G, et al. The anti-metastatic agent imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate induces endothelial cell apoptosis by inhibiting the mitogen-activated protein kinase/extracellular signal-regulated kinase signaling pathway. Arch Biochem Biophys 2002;403:209-18.
77. Pavlovic D, Andersen NA, Mandrup-Poulsen T, Eizirik DL. Activation of extracellular signal-regulated kinase (ERK)1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic beta-cells. Eur Cytokine Netw 2000;11:267-74.